While generally a self-limiting condition, hand, foot, and mouth disease (HFMD) can spread very quickly, particularly among children attending childcare centres. Dr Chan Si Min, Head and Senior Consultant at the Division of Paediatric Infectious Diseases, National University Hospital, Singapore, talks to Roshini Claire Anthony about the complications and management of HFMD.
A study with limited case data reveals a shorter duration of viral shedding of SARS-CoV-2, the causative agent of the novel coronavirus disease (COVID-19), through the upper respiratory tract in children compared with adults.
Multisystem inflammatory syndrome (MIS) in critically ill children with the coronavirus disease 2019 (COVID-19) is more varied than previously thought, according to a new study. Despite this, complete recovery appears to be almost universal.
Greater screen exposure and less social play time in early life is associated with autism spectrum disorder (ASD)-like symptoms at age 2, although ASD risk was not increased, suggests an observational cohort study.
A newly developed noninvasive and noncontact bilirubin measurement device has shown reliability in the assessment of total serum bilirubin (TSB) levels in preterm and term neonates regardless of gestational or postnatal age, sex, risk factors, feeding behaviour, or skin colour, reports a study.
Once-daily treatment with viloxazine extended release, also known as SPN-812, is safe and effective in children aged 6–11 years with attention-deficit/hyperactivity disorder (ADHD), yielding rapid improvements in symptoms and function, according to the results of a phase III trial.
Antiviral treatment with tenofovir alafenamide fumarate (TAF) during pregnancy in highly viraemic mothers effectively prevents mother-to-child transmission (MTCT) of hepatitis B virus (HBV) with no safety concerns, according to two studies presented during the AASLD 2020 Liver Meeting.